DANIEL M KAPLON NPI 1265651061

NPI Details

Daniel M Kaplon is an urology in Sarasota, FL with 23 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Daniel M Kaplon NPI is 1265651061. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2003

The provider's business location address is:

1921 WALDEMERE ST STE 310
SARASOTA, FL
ZIP 34239-941
Phone: (941) 917-5400
Fax: (941) 917-5420

The NPI 1265651061 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Biopsy of prostate gland (HCPCS:55700)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Unclassified drugs (HCPCS:J3490)
• Imaging guidance for procedure, 60 minutes or less (HCPCS:76000)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Placement of hormone pellet under skin (HCPCS:11980)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Surgical removal of prostate and surrounding lymph nodes using an endoscope (HCPCS:55866)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Removal of lymph nodes of both sides of pelvis using an endoscope (HCPCS:38571)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope (HCPCS:52001)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Destruction and/or removal of large growth of bladder using an endoscope (HCPCS:52240)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 4/24/2007 and was last updated on 3/3/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.